CSL - Ebitda

Aktienkurs
141.15
Täglich Wechseln
0.49 0.35%
Monatlich
-7.59%
Jährlich
-43.01%
Q1 Prognose
138.07




Ebitda Veränderung Datum
Alterity Therapeutics Limited AUD -7.72M 2.99M 2023-06
Arca Biopharma USD -25.07M 5.23M 2025-03
aTyr Pharma USD -26.58M 26.32M 2025-09
Bio Path USD -3.21M 631K 2025-03
Brainstorm Cell Therapeutics USD -3.04M 99K 2025-03
Cara Therapeutics USD -2.39M 3.16M 2025-03
CSL USD 3.13B 1.17B 2025-12
Curis USD -12.3M 231K 2023-09
Esperion Therapeutics USD -9.93M 24.99M 2025-09
Immunic USD -22.78M 753K 2024-06
Infinity Pharmaceuticals USD -10.01M 1.39M 2023-06
Minerva Neurosciences USD -4.36M 1.71M 2024-09
TherapeuticsMD USD -1.64M 700K 2023-09